Literature DB >> 28236916

Risk factors for stent graft-induced new entry after thoracic endovascular aortic repair for Stanford type B aortic dissection.

Hyunsik Jang1, Man-Deuk Kim2, Gyoung Min Kim1, Jong Yun Won1, Young-Guk Ko3, Donghoon Choi3, Hyun-Chul Joo4, Do Yun Lee1.   

Abstract

OBJECTIVE: Stent graft-induced new entry (SINE) has been increasingly observed after thoracic endovascular aortic repair (TEVAR) for Stanford type B aortic dissection. SINE is often life threatening, and reintervention is required. This study investigated risk factors for SINE after TEVAR.
METHODS: From July 2001 to June 2013, we retrospectively analyzed data from 79 patients who underwent TEVAR for Stanford type B aortic dissection. TEVAR was performed in 17 patients ≤2 weeks (acute) after the diagnosis of aortic dissection and in the remaining 62 patients >2 weeks (chronic) after diagnosis. Forty-two of the patients underwent TEVAR with modified stent graft with an "inwardly bent" margin, and the remaining 37 underwent TEVAR with a conventional stent graft. The maximal diameter, minimal diameter, mean diameter, circumference, and area of the true lumen were analyzed. Taper ratio and oversizing ratio were evaluated and compared between the SINE and non-SINE groups, and cutoff values of taper ratio and oversizing ratio for prediction of SINE were determined using receiver-operating characteristic curve analysis. The cumulative incidence of SINE was estimated with the Kaplan-Meier method. The multivariate Cox proportional hazards model was used to identify independent predictive variables for SINE.
RESULTS: SINE occurred in 21 patients (26.5%) and occurred more frequently in patients with chronic dissection than in those with acute dissection (32.3% vs 5.9%; P = .032). The Kaplan-Meier curves were significantly different (P = .016) between these groups. The incidence of SINE events was not significantly different between the modified stent group and nonmodified stent group (23.8% vs 36.0%; P = .284). The taper ratio and oversizing ratio by maximal diameter, mean diameter, circumference, and area were significantly higher in the SINE group than in the non-SINE group, and Kaplan-Meier curves were significantly different between groups above and below optimal cutoff value (P < .0005 to .003). According to multivariate analysis, the hazard ratios of chronic aortic dissection were 6.30 (95% confidence interval, 0.83-47.74; P = .075) to 7.80 (95% confidence interval, 1.03-59.07; P = .047). The taper ratio and oversizing ratio calculated by maximal diameter, mean diameter, circumference, and area were independent predictors of the development of SINE.
CONCLUSIONS: Distal oversizing of the stent graft was an independent predictor of the development of SINE. Appropriate size selection of stent graft without distal oversizing might reduce the risk of late SINE events.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28236916     DOI: 10.1016/j.jvs.2016.09.022

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

1.  Midterm outcomes of thoracic endovascular repair for uncomplicated type B aortic dissection with double-barrel type.

Authors:  Atsushi Omura; Hitoshi Matsuda; Tetsuya Fukuda; Yoshikatsu Nomura; Ryota Kawasaki; Hirohisa Murakami; Akitoshi Yamada; Kunio Gan; Nobuhiko Mukohara; Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-04-30

2.  Thoracic endovascular aortic repair for the treatment of ruptured acute type B aortic dissection.

Authors:  Shuji Chino; Noriyuki Kato; Ken Nakajima; Takashi Hashimoto; Takatoshi Higashigawa; Takafumi Ouchi; Hiroaki Kato; Naoki Yamamoto; Hisato Ito; Yasumi Maze; Toshiya Tokui; Hajime Sakuma
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

Review 3.  How should we manage type B aortic dissections?

Authors:  J Fleerakkers; M Schepens
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-29

Review 4.  Endovascular Repair in Acute Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US Investigational Device Exemption Study.

Authors:  Chang Young Lim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-06-05

5.  Equations for Estimating the Predissected Diameter of the Descending Aorta From Computed Tomographic Images at the Onset of Aortic Dissection.

Authors:  Takashi Yamauchi; Takafumi Masai; Hiroshi Takano; Yukitoshi Shirakawa; Koichi Toda; Yoshiki Sawa
Journal:  J Am Heart Assoc       Date:  2018-06-26       Impact factor: 5.501

6.  Mid-Term Results of Frozen Elephant Trunk Technique for Chronic Aortic Dissection.

Authors:  Yoshitaka Yamane; Keijiro Katayama; Tomokuni Furukawa; Haruna Shimizu; Takanobu Okazaki; Taiichi Takasaki; Tatsuya Kurosaki; Shinya Takahashi
Journal:  Ann Vasc Dis       Date:  2020-06-25

7.  Virtual stenting with simplex mesh and mechanical contact analysis for real-time planning of thoracic endovascular aortic repair.

Authors:  Duanduan Chen; Jianyong Wei; Yiming Deng; Huanming Xu; Zhenfeng Li; Haoye Meng; Xiaofeng Han; Yonghao Wang; Jia Wan; Tianyi Yan; Jiang Xiong; Xiaoying Tang
Journal:  Theranostics       Date:  2018-11-10       Impact factor: 11.556

8.  Ab ovo: Factors Affecting the Radial Stiffness of Thoracic Aorta Stent-Grafts.

Authors:  I Yu Zhuravleva; T P Timchenko; S V Vladimirov; M M Lyashenko; E V Kuznetsova; A M Chernyavskiy
Journal:  Sovrem Tekhnologii Med       Date:  2021-02-28

9.  Clinical Results and Aortic Remodeling After Endovascular Treatment for Complicated Type B Aortic Dissection With the "Fabulous" Stent System.

Authors:  Ruihan Wang; Yuanqing Kan; Mou Yang; Hongkun Zhang; Xiaoming Zhang; Xiangchen Dai; Shuiting Zhai; Hejie Hu; Xiwei Zhang; Bing Chen; Jianhua Huang; Xiao Qin; Zhanxiang Xiao; Xinwu Lu; Wei Guo; Yi Si; Weiguo Fu
Journal:  Front Cardiovasc Med       Date:  2022-02-14

10.  Endovascular repair of type B aortic dissection with the restrictive bare stent technique: morphologic changes, technique details, and outcomes.

Authors:  Binshan Zha; Geliang Xu; Huagang Zhu; Wentao Xie; Zhigong Zhang; Yongsheng Li; Peng Qiu
Journal:  Ther Clin Risk Manag       Date:  2018-10-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.